Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1949-58. doi: 10.1007/s00259-012-2205-x. Epub 2012 Aug 11.
[(18)F]SP203 (3-fluoro-5-(2-(2-([(18)F]fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile) is an effective high-affinity and selective radioligand for imaging metabotropic 5 receptors (mGluR5) in human brain with PET. To provide a radioligand that may be used for more than one scanning session in the same subject in a single day, we set out to label SP203 with shorter-lived (11)C (t (1/2) = 20.4 min) and to characterize its behavior as a radioligand with PET in the monkey.
Iodo and bromo precursors were obtained by cross-coupling 2-fluoromethyl-4-((trimethylsilyl)ethynyl)-1,3-thiazole with 3,5-diiodofluorobenzene and 3,5-dibromofluorobenzene, respectively. Treatment of either precursor with [(11)C]cyanide ion rapidly gave [(11)C]SP203, which was purified with high-performance liquid chromatography. PET was used to measure the uptake of radioactivity in brain regions after injecting [(11)C]SP203 intravenously into rhesus monkeys at baseline and under conditions in which mGluR5 were blocked with 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP). The emergence of radiometabolites in monkey blood in vitro and in vivo was assessed with radio-HPLC. The stability of [(11)C]SP203 in human blood in vitro was also measured.
The iodo precursor gave [(11)C]SP203 in higher radiochemical yield (>98 %) than the bromo precursor (20-52 %). After intravenous administration of [(11)C]SP203 into three rhesus monkeys, radioactivity peaked early in brain (average 12.5 min) with a regional distribution in rank order of expected mGluR5 density. Peak uptake was followed by a steady decline. No radioactivity accumulated in the skull. In monkeys pretreated with MTEP before [(11)C]SP203 administration, radioactivity uptake in brain was again high but then declined more rapidly than in the baseline scan to a common low level. [(11)C]SP203 was unstable in monkey blood in vitro and in vivo, and gave predominantly less lipophilic radiometabolites. By contrast, [(11)C]SP203 was stable in human blood in vitro.
[(11)C]SP203 emulates [(18)F]SP203 with regard to providing a sizeable mGluR5-specific signal in monkey brain, and advantageously avoids troublesome accumulation of radioactivity in bone. Although [(11)C]SP203 is unsuitable for mGluR5 quantification in monkey brain, its evaluation as a PET radioligand for studying human brain mGluR5 is nevertheless warranted.
[(18)F]SP203(3-氟-5-(2-(((18)氟甲基)-噻唑-4-基)乙炔基)苯甲腈)是一种有效的高亲和力和选择性代谢型 5 型谷氨酸受体(mGluR5)成像放射性配体,可用于 PET 检测人脑中的 mGluR5。为了提供一种可在同一天内用于同一受试者多次扫描的放射性配体,我们着手用半衰期更短的(11)C(t 1/2=20.4 分钟)标记 SP203,并研究其作为放射性配体在猴子体内的 PET 行为。
通过将 2-氟甲基-4-((三甲基甲硅烷基)乙炔基)噻唑与 3,5-二碘氟苯和 3,5-二溴氟苯分别进行交叉偶联,得到碘和溴的前体。用[(11)C]氰化物离子快速处理任一前体,即可得到[(11)C]SP203,并用高效液相色谱法进行纯化。将[(11)C]SP203静脉注射到恒河猴体内,在基线和 mGluR5 被 3-[(2-甲基-1,3-噻唑-4-基)乙炔基]吡啶(MTEP)阻断的条件下,用 PET 测量放射性示踪剂在大脑区域的摄取。用放射性高效液相色谱法评估放射性代谢产物在猴血体外和体内的出现情况。还测量了[(11)C]SP203 在人血体外的稳定性。
碘前体的放射化学产率(>98%)高于溴前体(20-52%),可得到[(11)C]SP203。将[(11)C]SP203 静脉注射到三只恒河猴体内后,放射性示踪剂在大脑中早期达到峰值(平均 12.5 分钟),脑内分布与预期的 mGluR5 密度顺序一致。峰值摄取后,放射性示踪剂逐渐下降。颅骨中没有放射性物质蓄积。在给予[(11)C]SP203 前用 MTEP 预处理的猴子中,大脑中的放射性摄取仍然很高,但随后比基线扫描更快地下降,达到一个共同的低水平。[(11)C]SP203 在猴血体外和体内不稳定,主要产生疏水性较小的放射性代谢产物。相比之下,[(11)C]SP203 在人血体外稳定。
[(11)C]SP203 在猴子大脑中提供了可观的 mGluR5 特异性信号,与[(18)F]SP203 类似,并且有利地避免了放射性物质在骨骼中的堆积。尽管[(11)C]SP203 不适合用于猴子大脑中 mGluR5 的定量,但仍有必要对其作为研究人类大脑 mGluR5 的 PET 放射性配体进行评估。